Results 1 to 10 of about 16,223 (208)
Longitudinal Videofluorographic Dysphagia Measures in Progressive Supranuclear Palsy. [PDF]
Mov Disord Clin PractAbstract Background Dysphagia can lead to fatal aspiration pneumonia in progressive supranuclear palsy (PSP). Little is known about the longitudinal progression of dysphagia or whether it differs across PSP clinical variants. Objectives To characterize longitudinal changes in dysphagia across PSP variants and determine relationships with disease ...
Cattani AC +8 more
europepmc +2 more sources
Zolpidem in Progressive Supranuclear Palsy [PDF]
Case Reports in Neurological Medicine, 2013 Progressive supranuclear palsy (PSP) is a progressive neurodegenerative disorder, characterized by motor symptoms, postural instability, personality changes, and cognitive impairment. There is no effective treatment for this disorder.
Sandip K. Dash
doaj +3 more sources
Genetics of Progressive Supranuclear Palsy [PDF]
Journal of Movement Disorders, 2015 Progressive supranuclear palsy (PSP) is a neurodegenerative syndrome that is clinically characterized by progressive postural instability, supranuclear gaze palsy, parkinsonism and cognitive decline.
Sun Young Im +2 more
doaj +3 more sources
Emerging Hypersexuality in a Patient With Progressive Supranuclear Palsy [PDF]
BJPsych OpenAims: Progressive supranuclear palsy (PSP) typically presents with a constellation of motor symptoms, most commonly with frequent falls and gait disturbances.
Pei Ling Lim, Boon Ceng Chai
doaj +2 more sources
Tremor in progressive supranuclear palsy [PDF]
Parkinsonism and Related Disorders, 2016 Tremor is thought to be a rare feature of progressive supranuclear palsy (PSP).We retrospectively reviewed the database of the CurePSP brain bank at Mayo Clinic Florida to retrieve all available clinical information for PSP patients. All patients underwent a standard neuropathological assessment and an immunohistochemical evaluation for tau and α ...
Wszolek Z +2 more
exaly +3 more sources
4R-tau seeding activity reveals molecular subtypes in progressive supranuclear palsy [PDF]
Nature CommunicationsProgressive supranuclear palsy (PSP) is a neurodegenerative disease characterized by abnormal accumulation of the protein tau in the brain, leading to motor and cognitive symptoms that vary between individuals. The reasons for this clinical heterogeneity
Ivan Martinez-Valbuena +21 more
doaj +2 more sources
Progressive supranuclear palsy [PDF]
Seminars in Neurology, 2001 Unfortunately, no drug treatment has been shown to benefit patients with progressive supranuclear palsy (PSP) more than modestly or briefly. The multiplicity of neuronal systems and synaptic physiologies that degenerate in this disorder makes a neurotransmitter-specific approach, such as neurotransmitter replacement or reuptake inhibition, unlikely to ...
K, Tawana, D B, Ramsden
openaire +5 more sources
Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database
Frontiers in Neurology, 2021 Background: Progressive supranuclear palsy is a rare neurodegenerative movement disorder and little is known about its epidemiology.Objective: Estimate age-adjusted prevalence of progressive supranuclear palsy and describe antecedent diagnoses and ...
Emma Viscidi +11 more
doaj +1 more source
Progressive supranuclear palsy [PDF]
Postgraduate Medical Journal, 2000 Abstract Progressive supranuclear palsy (PSP) or Steele-Richardson-Olszewski syndrome is a neurodegenerative disease of middle and late age. It is under-diagnosed not only by general physicians but also by neurologists. The cause of PSP is not known.
, Lowrey, , Wong
openaire +4 more sources
Journal of Medical Case Reports, 2021 Background Progressive supranuclear palsy is a neurodegenerative condition that worsens over time. Given the lack of targeted treatments, patients with severe progressive supranuclear palsy have very low life expectancy.
Huiping Li +7 more
doaj +1 more source